Retrospective Real World Evidence of Patients Infused with Commercially Released AMTAGVI (lifileucel) for Unresectable or Metastatic Melanoma - HonorHealth Research Institute

Trial Details

Principal Investigator: Moser, Justin
Condition(s): Metastatic Melanoma, Unresectable Melanoma
Sponsor: HRI

Email

Overview

Retrospective Real World Evidence of Patients Infused with Commercially Released AMTAGVI (lifileucel) for Unresectable or Metastatic Melanoma

Trial Contact

Amy Stoll dastice

833-354-6667 Oncology [email protected]

Oncology HRI Early Detection